US SB1049 | 2017-2018 | 115th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 4 2017 - 25% progression, died in committee
Action: 2017-05-04 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 4 2017 - 25% progression, died in committee
Action: 2017-05-04 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Opioid Addiction Risk Transparency Act This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require a communication plan that is part of a medication's risk evaluation and mitigation strategy to include informing health care providers about the meaning of terms related to properties of the medication described in the labeling.
Title
Opioid Addiction Risk Transparency Act
Sponsors
Sen. Margaret Hassan [D-NH] | Sen. Todd Young [R-IN] |
History
Date | Chamber | Action |
---|---|---|
2017-05-04 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
SB934 (Related) 2017-05-11 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 76.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/115th-congress/senate-bill/1049/all-info |
Text | https://www.congress.gov/115/bills/s1049/BILLS-115s1049is.pdf |